Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Topical estrogen therapy for hyperopia correction in vivo
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Topical estrogen therapy for hyperopia correction in vivo'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Estrogen
100%
Treatment Group
100%
Topical Estrogen
100%
Hyperopia Correction
100%
Intraocular Pressure
66%
Eye Drops
66%
Keratometry Reading
66%
Keratometry
66%
Myopic Shift
66%
Pachymetry
66%
No Significant Difference
33%
Between-group
33%
17-estradiol
33%
Tissue Stiffness
33%
Pharmacological Therapy
33%
In Vitro Study
33%
Cornea
33%
Refractive Error
33%
Refractive Properties
33%
Hyperopic Shift
33%
Diopter
33%
New Zealand White Rabbit
33%
Corneal Refractive Power
33%
Refraction
33%
Ocular Examination
33%
Treatment Cessation
33%
Repeated Measures Analysis
33%
Rate of Change
33%
Right Eye
33%
Corneal Biomechanics
33%
Corneal Flattening
33%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Leporidae
100%
Diethylstilbestrol
100%
Hypermetropia
100%
New Zealand White (Rabbit)
100%
Refraction Error
100%
Medicine and Dentistry
Estrogen Therapy
100%
Corneal Topography
100%
Hyperopia
100%
Intraocular Pressure
50%
Pachymetry
50%
Side Effect
25%
In Vitro
25%
Diethylstilbestrol
25%
Refractive Error
25%
Eye Examination
25%
Nursing and Health Professions
Estrogen Therapy
100%
Corneal Topography
100%
Hypermetropia
100%
Intraocular Pressure
50%
Pachymetry
50%
Rigidity
25%
Side Effect
25%
Refraction Error
25%
Diethylstilbestrol
25%
Eye Examination
25%
Veterinary Science and Veterinary Medicine
Diethylstilbestrol
100%